MedTrace Logo

Physiological, Behavioral and Subjective Effects of Drugs (GHB)

NCT00058955 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2008-09-10

No results posted yet for this study

Summary

The purpose of this study is to learn more about the effects of gamma-hydroxybutyric acid (GHB) by comparing its physiological, behavioral and subjective effects with those of several other drugs.

Conditions

  • Sedative Abuse

Interventions

DRUG

sodium oxybate, triazolam and pentobarbital

sodium oxybate, triazolam and pentobarbital

Sponsors & Collaborators

Principal Investigators

  • Roland Griffiths, PhD · Johns Hopkins University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2003-08-31
Completion
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00058955 on ClinicalTrials.gov